D-0272-2022 Class III Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0272-2022 was initiated by Dr. Reddy's Laboratories, Inc. on Nov 12, 2021 and is designated Class III. Reason for recall: Failed dissolution specifications The recall status is terminated (terminated Jun 23, 2023). Affected quantity: 2496 cartons.

Recall details

Product Type
Drugs
Report Date
Dec 15, 2021
Initiation Date
Nov 12, 2021
Termination Date
Jun 23, 2023
Product Quantity
2496 cartons

Product description

12 HR Allergy & Congestion Relief Fexofenadine HCl, 60 mg I Pseudoephedrine HCl, 120 mg Antihistamine I Nasal Decongestant, 20 Extended-Release Tablets USP, Distributed By Cardinal Health, Dublin, Ohio 43107, Made in India, NDC 70000-0518-1.

Reason for recall

Failed dissolution specifications

Distribution pattern

USA Nationwide.

Code information

Lot #: AC2103329G, Exp 1/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0272-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0272-2022. Report a data issue: hello@regdatalab.com.